Morgan Stanley’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1M | Buy |
|
|||||
|
2025
Q1 | $19.6M | Buy |
|
|||||
|
2024
Q4 | $18.5M | Buy |
|
|||||
|
2024
Q3 | $6.53M | Buy |
|
|||||
|
2024
Q2 | $2.27M | Sell |
|
|||||
|
2024
Q1 | $3.85M | Sell |
|
|||||
|
2023
Q4 | $22.4M | Buy |
|
|||||
|
2023
Q3 | $5.02M | Buy |
|
|||||
|
2023
Q2 | $1.22M | Sell |
|
|||||
|
2023
Q1 | $1.68M | Buy |
|
|||||
|
2022
Q4 | $184K | Buy |
|
|||||
|
2022
Q3 | $42K | Sell |
|
|||||
|
2022
Q2 | $46K | Buy |
|
|||||
|
2022
Q1 | $25K | Sell |
|
|||||
|
2021
Q4 | $632K | Buy |
|
|||||
|
2021
Q3 | $271K | Sell |
|
|||||
|
2021
Q2 | $329K | Buy |
|